Clinical trial
Gabapentin Treatment of Cannabis Dependence
NCT00974376 is registered in ClinicalTrials.gov with The Scripps Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gabapentin Treatment of Cannabis Dependence
- Lead sponsor
- The Scripps Research Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 4, 2009
- Completion date
- May 19, 2016
- Enrollment
- 150 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cannabis dependence, cannabis withdrawal, cognitive deficits